The endothelin receptor antagonist CPU0213 is more effective than aminoguanidine to attenuate isoproterenol-induced vascular abnormality by suppressing overexpression of NADPH oxidase [correction of oxidas], ETA, ETB, and MMP9 in the vasculature (Q46507090)
Jump to navigation
Jump to search
scientific article published in July 2008
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | The endothelin receptor antagonist CPU0213 is more effective than aminoguanidine to attenuate isoproterenol-induced vascular abnormality by suppressing overexpression of NADPH oxidase [correction of oxidas], ETA, ETB, and MMP9 in the vasculature |
scientific article published in July 2008 |
Statements
1 reference
The endothelin receptor antagonist CPU0213 is more effective than aminoguanidine to attenuate isoproterenol-induced vascular abnormality by suppressing overexpression of NADPH oxidase [correction of oxidas], ETA, ETB, and MMP9 in the vasculature (English)
1 reference
Jin Xu
1 reference
Na Li
1 reference
De-Zai Dai
1 reference
Feng Yu
1 reference
Yin Dai
1 reference
1 July 2008
1 reference
52
1 reference
1
1 reference
42-48
1 reference